Last reviewed · How we verify

Various (various)

Pfizer · FDA-approved active Quality 30/100

Pfizer's drug is a marketed treatment for various bacterial infections. It has a revenue of $63.6 billion and has been involved in 100 trials. The drug's mechanism is not specified on Wikipedia. It is indicated for acute bacterial exacerbation of chronic bronchitis, acute bacterial sinusitis, acute pyelonephritis, community-acquired bacterial pneumonia, and complicated urinary tract infections. The drug's clinical differentiation and commercial significance are not specified. There are no pipeline developments mentioned.

At a glance

Generic namevarious
SponsorPfizer
Drug classAntibiotic
TargetNot specified
Therapeutic areaImmunology
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Drug interactions

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results